|
contents | europe | ||||
| Roquette Pharma at CPhI 2008 Roquette Pharma, a longstanding supplier of high-quality raw materials and excipients for pharmaceutical and cosmetic applications, will be showcasing a selection of its key product ranges at CPhI Worldwide, Messe Frankfurt, Germany, September 30 – October 2 2008, stand 60D05. Roquette develops ingredients and excipients from natural harvests such as wheat, maize, pea and potatoes. Roquette offers a comprehensive product portfolio, ranging from starches and sugars to speciality products including polyols and cyclodextrins. New on Roquette's stand at CPhI will be ReadiLYCOATTM. Roquette recently has announced a European strategic partnership with Biogrund for the development of ReadiLYCOAT, a new ready-to-use film coating platform for pharmaceutical and nutraceutical applications. Utilising Roquette's new starch-based film coating polymer LYCOAT, ReadiLYCOAT has opened the way for a series of remarkable advances in film coating. Most notably, ReadiLYCOATTM offers a dramatic reduction in coating time and does not affect the dissolution and stability, regardless of the API. Roquette's LYCOAT is an aqueous film coating polymer which ensures low viscosity dispersions at a high solids content. Its excellent film integrity and adhesion qualities provide additional advantages. Among the product brands shown on stand 60D05 will be PEARLITOL, Roquette's mannitol range. With very low hygroscopicity and exceptional chemical stability, PEARLITOL mannitol offers the ideal solution in excipients for stable formulations. In addition, PEARLITOL offers grades for a wide range of applications from classical tablets and capsules to sachets. Also showcased on stand 60D05 will be Roquette's KLEPTOSE, a second generation range of modified betacyclodextrins. Together with different substituted betacyclodextrins, the KLEPTOSE range caters for the specific needs of the pharmaceutical and cosmetic industry. The pioneering Roquette range offers several advantages including the possibility of increased solubilisation power while maintaining a high biological tolerance. write your comments about the article :: © 2008 Exhibition News :: home page |